A Pap smear can be taken during a period, and the CDC says both the Pap and the HPV test can still be done at that time. Most labs and clinics still prefer a day when you are not bleeding, because blood can hide cervical cells and lead to an unreadable sample. If your period starts on the day of the test, ring the clinic: they will either go ahead, especially if bleeding is light, or move the appointment.
Can a Pap smear be taken while you are bleeding?
Yes, a Pap smear can be taken while you are bleeding, but most services ask you to come on a day without a period. The CDC's cervical cancer screening page is direct: "If you have your period, don't worry. Both tests can still be done at this time." The NHS takes a more cautious line and says it is best to book cervical screening for a time when you are not having a period; if your period starts on the day of the test, the NHS asks you to contact your GP surgery to rearrange.
US clinics sit between the two. Cleveland Clinic says it is best to avoid a Pap test while on your period because bleeding could alter the result, but adds that some providers will test at the end of a period when bleeding is light. MedlinePlus says you should not have a Pap smear during your period and suggests a window of about five days after the period ends.
The practical rule is simple. Light spotting or the last day of a period rarely stops the test. Heavy flow on day one or two is the reason clinics reschedule. If you are unsure, ring the clinic or your gynaecologist before you travel, and say which day of your period you are on. If you are booking at a diagnostic centre in India, that one call saves a wasted trip.
Why does menstrual blood affect the sample?
Menstrual blood affects the sample because it can cover the cervical cells the lab needs to read. MedlinePlus explains that a Pap result comes back "unsatisfactory" when the sample did not have enough cells, or when cells are clumped together or hidden by mucus; the provider then asks you to return for another test in a few months. Cleveland Clinic calls the same outcome an "unclear" result and says a repeat Pap may be needed.
The best evidence on timing comes from a 2006 study in the British Journal of Cancer by Sherman, Carreon and Schiffman. They examined 5,060 women in the ASCUS-LSIL Triage Study and grouped liquid-based Pap samples by the day of the menstrual cycle. Unsatisfactory samples were uncommon overall but clustered early in the cycle:
| Cycle timing | Unsatisfactory samples |
|---|---|
| Days 0 to 10 (period and the days after) | 25 of 5,384 (0.46%) |
| Mid-cycle | 5 of 6,792 (0.07%) |
| Late cycle | 8 of 3,213 (0.25%) |
The authors concluded that the date of the last period "is not a critical clinical consideration" for the test, while adding that mid-cycle scheduling is still prudent when possible. In plain words: a sample taken on your period has a higher chance of needing a repeat, but the chance is still under one in two hundred with modern liquid-based cytology.
What else should you avoid in the two days before the test?
You should avoid anything that goes into the vagina for two days before the test, because it can wash away or coat the cells. The sources agree on the list, with small differences in wording:
- Vaginal sex: the CDC and Cleveland Clinic say avoid it for two days; the CDC adds that if you did have sex, go to the appointment as planned and tell the doctor.
- Douching: the CDC, Cleveland Clinic and MedlinePlus all list it.
- Vaginal medicines, creams, pessaries and lubricants: the NHS says avoid them in the two days before you go because they can affect the result.
- Spermicidal foam, jelly or cream: listed by the CDC and MedlinePlus.
- Tampons: Cleveland Clinic and MedlinePlus say avoid them for two days before.
The NHS makes one exception. If you are going through the menopause and find the test painful, your GP can prescribe a vaginal oestrogen cream or pessary to use before the test. That is a doctor's decision, not something to buy over the counter.
None of these rules apply to the HPV test on its own. The CDC states that "no special preparation is needed before you have an HPV test". Where a clinic takes one sample for both tests, which is now the norm in the NHS and in co-testing in the US, follow the Pap rules anyway, because the same brush collects the cells.
Does HPV testing change the answer?
HPV testing makes the timing of the sample matter less, because the test looks for a virus rather than for cell shapes. In the 2006 British Journal of Cancer study, the frequency of positive Hybrid Capture 2 HPV results "were unrelated to the date of LMP" (last menstrual period). Mid-cycle samples showed a slightly higher viral load, but the authors described the effect as small.
The NHS now runs its programme HPV-first. The sample is checked for high-risk types of human papillomavirus; only if those are found are the cells examined for abnormal changes. The NHS states that "nearly all cervical cancers are caused by infection with high risk types of HPV", and that without a high-risk type cervical cancer is very unlikely. The US National Cancer Institute says the same in different words: "Virtually all cervical cancer is caused by HPV", with HPV 16 and 18 responsible for most HPV-related cancers.
The virus works slowly. The NCI says it can take 5 to 10 years for HPV-infected cervical cells to develop into precancers and about 20 years to develop into cancer. That is why screening every three to five years catches most problems in time, and why one delayed appointment because of a period is not a disaster. Rebook rather than skip.
The NCI also notes that HPV vaccination offers the most protection when given to girls and boys at ages 9 to 12, and is recommended up to age 26 for those not vaccinated earlier. Vaccination does not replace screening; vaccinated women are still invited.
At what age and how often should screening happen?
Screening starts between 21 and 30 depending on the country, and repeats every three to five years. The three programmes a HealthFinder reader is most likely to come across differ as follows:
| Programme | Age range | Test and interval |
|---|---|---|
| India (MoHFW Operational Framework, 2016, per CDC MMWR) | 30 to 65 | Visual inspection with acetic acid (VIA) every 5 years |
| NHS England | 25 to 64 | HPV-first sample every 5 years |
| US (USPSTF 2018) | 21 to 29 | Cytology (Pap) alone every 3 years |
| US (USPSTF 2018) | 30 to 65 | Pap every 3 years, or HPV alone every 5 years, or HPV plus Pap (co-testing) every 5 years |
The USPSTF recommends against screening women younger than 21, women who have had a hysterectomy with removal of the cervix and no history of high-grade precancer, and women over 65 who have had adequate prior screening. The CDC adds that a doctor may stop screening after 65 if you have had three normal Pap tests or two normal HPV tests in the past 10 years.
Cleveland Clinic lists groups who need more frequent screening or screening past 65: people with HIV or a weakened immune system, prior DES exposure, a history of cervical cancer, or past abnormal results. If you fall into one of these groups, your gynaecologist sets the interval, not the table above.
What is the cervical screening programme in India?
India's programme offers screening by visual inspection with acetic acid (VIA) every five years to women aged 30 to 65, delivered through the government health system. A 2019 CDC MMWR report on baseline screening coverage in India records that the Ministry of Health and Family Welfare's 2016 Operational Framework recommended "cervical cancer screening using visual inspection with acetic acid every 5 years for women aged 30 - 65 years", following WHO guidance. The same report gives India's burden as an estimated 96,922 new cervical cancer cases and 60,078 deaths each year.
VIA is not a Pap smear. The name describes the method: the cervix is inspected by eye after acetic acid is applied, and no sample goes to a laboratory. The NFHS-5 analysis cited below describes the programme as using VIA or VILI (Lugol's iodine) under the National Health Mission. Ask the same timing question before a VIA visit.
Uptake remains low. A 2022 analysis of NFHS-5 (2019 to 2021) data in the Journal of Family Medicine and Primary Care found that only 1.9% of women aged 30 to 49 had ever been screened for cervical cancer (2.2% urban, 1.7% rural), ranging from 0.2% in Gujarat, Assam and West Bengal to 9.8% in Tamil Nadu.
Where to go: a government primary health centre or district hospital runs the programme. A Pap smear or HPV test at a private diagnostic centre or through a gynaecologist is the alternative; many hospitals also list it under women's health packages. Carry your last report if you have one.
What happens during the test and afterwards?
The test itself takes under five minutes. The NHS describes it: the nurse or doctor inserts a speculum, "a smooth, tube-shaped tool", opens it to see the cervix, and "using a soft brush, they'll take a small sample of cells from your cervix". You can ask for a smaller speculum, ask to insert it yourself, or ask to stop at any time. The whole appointment is about 10 minutes.
Afterwards you may have light bleeding or spotting, which the NHS says should stop within a few hours. Cleveland Clinic says results can take up to three weeks and come back as normal, unclear or abnormal; an abnormal result usually leads to a colposcopy, not straight to treatment.
See a doctor the same day if bleeding after the test is heavy, if spotting continues beyond a few hours, or if you have fever or severe pelvic pain. Bleeding between periods or after sex at any other time also needs a check. In an emergency in India call 112.
If you were tested on your period and the report says "unsatisfactory", that is a comment on the sample, not on your cervix. Book the repeat for mid-cycle. This guide is general information from the sources listed below, not medical advice; a registered doctor makes decisions with you.
